Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

39.05USD
19 Dec 2014
Price Change (% chg)

$-1.43 (-3.53%)
Prev Close
$40.48
Open
$40.42
Day's High
$40.42
Day's Low
$37.45
Volume
1,211,509
Avg. Vol
311,396
52-wk High
$57.89
52-wk Low
$23.61

XLRN.O

Chart for XLRN.O

About

Acceleron Pharma Inc. is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company’s research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of... (more)

Overall

Beta: --
Market Cap (Mil.): $1,259.49
Shares Outstanding (Mil.): 32.25
Dividend: --
Yield (%): --

Financials

  XLRN.O Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -1.71 -- --
ROI: -34.46 -0.72 18.25
ROE: -42.74 -1.88 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks